4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0002021238-26-000012
Chief Discovery Officer acquired 6,020 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kreitzer Anatol · Chief Discovery Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-17 | Grant or award : show line 1 in the form | +6,020 | 180,926 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-17 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +24,455 | 24,455 | D |
Loading xslF345X06/form4-08192026_060813.xml…